专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20180185430A1 Herbal Composition for Shrimp Disease 审中-公开
公开(公告)号：US20180185430A1
公开(公告)日：2018-07-05
申请号：US15396165
申请日：2016-12-30
申请人： Yujia Zhu , Yahuan Cui
发明人： Yujia Zhu , Yahuan Cui
IPC分类号： A61K36/718 , A61K47/46 , A61K36/28 , A61K36/34 , A61K47/26
CPC分类号： A61K36/718 , A23K10/30 , A23K50/80 , A61K36/34 , A61K2300/00
摘要： A composition of herbal medicine which can be used for shrimp disease treatment, includes the following ingredients: Lobelia chinensis Lour, Folium Loropetali, composition X and fishmeal, crude protein, soymeal, powder, dextrin, glucose and minerals. The composition is used in manufacturing three different medicaments and for the different medicaments, the composition X includes one or more ingredients of astragalus, vitexin flower, elephantopus flower and Coptis chinensis leaf. The composition and the medicaments are effective in treating the shrimp infectious disease, protozoa and improving the shrimp immune system.

2. 发明授权

US09844575B2 Pharmaceutical composition and functional food comprising natural extracts for preventing or treating diabetic complications or angiodema 有权
公开(公告)号：US09844575B2
公开(公告)日：2017-12-19
申请号：US14759471
申请日：2014-01-10
申请人： KOREA INSTITUTE OF ORIENTAL MEDICINE
发明人： Jin Sook Kim , Jung Hyun Kim , Chan Sik Kim , Young Sook Kim , Eun Jin Shon , Yun Mi Lee , Dong Ho Jung , Ik Soo Lee , Gyu Hyeong Jo , Joo Hwan Kim
IPC分类号： A61K36/00 , A61K36/25 , A61K31/155 , A61K36/708 , A61K36/488 , A61K36/16 , A61K36/482 , A61K36/45 , A61K36/73 , A61K36/87 , A61K36/718 , A23L33/105
CPC分类号： A61K36/25 , A23L33/105 , A23V2002/00 , A61K31/155 , A61K36/16 , A61K36/45 , A61K36/482 , A61K36/488 , A61K36/708 , A61K36/718 , A61K36/73 , A61K36/87 , A61K2300/00
摘要： The present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema containing a mixed extract of Hedera helix leaves and Coptis chinensis as an active ingredient. More specifically, the present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema further containing an extract of Rheum palmatum, Puerariae radix, Ginkgo leaves, Cassiae semen, blueberry, bilberry, raspberry, or grape seeds as an active ingredient, in addition to the mixed extract of Hedera helix leaves and Coptis chinensis.

3. 发明申请

US20170319475A1 Medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, preparation method therefor and use method thereof 审中-公开
公开(公告)号：US20170319475A1
公开(公告)日：2017-11-09
申请号：US14901060
申请日：2015-05-29
申请人： Darong LIU
发明人： Darong LIU
IPC分类号： A61K9/00 , A61K36/489 , A61K36/236 , A61K36/32 , A61K36/58 , A61K9/08 , A61K36/00
CPC分类号： A61K9/0053 , A61K9/0095 , A61K9/08 , A61K33/06 , A61K35/10 , A61K35/36 , A61K36/00 , A61K36/11 , A61K36/23 , A61K36/232 , A61K36/234 , A61K36/236 , A61K36/24 , A61K36/32 , A61K36/324 , A61K36/40 , A61K36/46 , A61K36/481 , A61K36/484 , A61K36/489 , A61K36/58 , A61K36/605 , A61K36/65 , A61K36/71 , A61K36/716 , A61K36/718 , A61K36/725 , A61K36/738 , A61K36/746 , A61K36/75 , A61K36/756 , A61K36/815 , A61K36/899 , A61K36/90 , A61K36/904 , A61K2300/00
摘要： The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use methods thereof. The medicine comprises: lightyellow sophora root, glabrous greenbrier rhizome, bark of Chinese corktree, raw sessile stemona root, alumen, coptis root, cortex dictamni, chinaberry bark and root-bark, pangolin scales, amber, eucommia bark, tree peony bark, clematis root, common cnidium fruit, Chinese angelica, licorice root, common macrocarpium fruit, barbary wolfberry fruit, medicinal indianmulberry root, cherokee rose fruit, chinaroot greenbier rhizome, akebia fruit, milkvetch root, Japanese climbing fern spore, asiatic pennywort herb, mulberry leaf and frankincense. The present invention not only provides the medicine capable of effectively treating the acquired immunodeficiency syndrome, but also enables the medicine to be capable of being used in conjunction with other medical technical means to easily achieve a more ideal treatment effect.

4. 发明申请

US20150231163A1 COMPOSITION FOR PREVENTING OR TREATING COLITIS 审中-公开
标题翻译：用于预防或治疗感染的组合物
公开(公告)号：US20150231163A1
公开(公告)日：2015-08-20
申请号：US14421770
申请日：2013-08-14
申请人： UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
发明人： Dong-Hyun Kim , Myung Joo Han , Se Eun Jang
IPC分类号： A61K31/7048 , A61K31/7032 , A61K31/4745 , A61K31/704 , A61K36/344 , A61K36/718 , A61K36/88 , A61K35/64
CPC分类号： A61K31/7048 , A23L33/105 , A61K9/08 , A61K9/19 , A61K31/4745 , A61K31/7032 , A61K31/704 , A61K35/63 , A61K35/64 , A61K36/22 , A61K36/344 , A61K36/718 , A61K36/88 , A61K36/8964 , A61K2300/00
摘要： The present invention relates to a novel use of an Anemarrhena asphodeloides Bunge extract and the like, and provides a composition for preventing or treating colitis, including an Anemarrhena asphodeloides Bunge extract, a fraction thereof or a compound isolated therefrom as an active ingredient. In addition, the present invention relates to a novel use of a combined extract of medicinal herbs, and provides a composition for preventing or treating colitis, including an Anemarrhena asphodeloides Bunge extract, a Galla Rhois extract, a Codonopsis lancellata extract, and the like as active ingredients, or including an Anemarrhena asphodeloides Bunge extract, a Coptis japonica Makino extract, and the like as active ingredients. According to the present invention, the Anemarrhena asphodeloides Bunge extract and the like or the combined extract can be used as a food or medical materials constituting a pharmaceutical composition or a nutraceutical composition. The pharmaceutical composition or the nutraceutical composition can be used for preventing or treating acute colitis or chronic colitis, and particularly, can effectively prevent, delay, alleviate or treat inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and the like.
摘要翻译：本发明涉及一种Anemarrhena asphodeloides Bunge提取物的新用途，并提供一种预防或治疗结肠炎的组合物，包括Anemarrhena asphodeloides Bunge提取物，其分数或其分离的化合物作为活性成分。此外，本发明涉及药草组合提取物的新用途，提供了预防或治疗结肠炎的组合物，包括Anemarrhena asphodeloides Bunge提取物，Galla Rhois提取物，Codonopsis lancellata提取物等作为活性成分，或者包括Anemarrhena asphodeloides Bunge提取物，黄连提取物等作为有效成分。根据本发明，可以将Anemarrhena asphodeloides Bunge提取物等或组合的提取物用作构成药物组合物或营养药物组合物的食品或医疗材料。药物组合物或营养药物组合物可用于预防或治疗急性结肠炎或慢性结肠炎，特别是可有效预防，延缓，缓解或治疗炎性肠病（IBD），肠易激综合征（IBS）等。

5. 发明申请

US20150119415A1 METHODS AND COMPOSITIONS FOR IMPROVING GUT MICROBIOTA POPULATION 审中-公开
标题翻译：改善胃肠微生物群体的方法和组合物
公开(公告)号：US20150119415A1
公开(公告)日：2015-04-30
申请号：US14405874
申请日：2013-06-04
申请人： SHANGHAI JIAO TONG UNIVERSITY , PERFECT (CHINA) CO., LTD
发明人： Liping Zhao , Xu Zhang , Menghui Zhang , Yufeng Zhao , Xiaoyan Pang , Xiaojun Zhang , Linghua Wang , Guang Ning , Xiaoying Li , Yifei Zhang
IPC分类号： A61K31/4375 , A23L1/29 , A23L1/30 , C12Q1/68 , G01N33/50
CPC分类号： A61K31/4375 , A23L33/105 , A23L33/30 , A23V2002/00 , A61K35/74 , A61K35/741 , A61K35/745 , A61K36/185 , A61K36/28 , A61K36/288 , A61K36/29 , A61K36/42 , A61K36/48 , A61K36/489 , A61K36/515 , A61K36/53 , A61K36/539 , A61K36/59 , A61K36/70 , A61K36/708 , A61K36/71 , A61K36/718 , A61K36/74 , A61K36/744 , A61K36/75 , A61K36/756 , A61K36/88 , A61K36/8964 , C12Q1/689 , C12Q2600/136 , G01N33/5088 , G01N2500/10 , A61K2300/00
摘要： A method and a composition for improving gut micro biota structure, selectively increase a first gut microbiota population while simultaneously decrease a second gut micro biota population in a subject. The first gut micro biota population includes a short-chain fatty acid (SCFA)-producing bacterium and the second gut microbiota population includes an endotoxin-producing bacterium.
摘要翻译：用于改善肠道微生物群结构的方法和组合物，选择性地增加第一肠道微生物群体群体同时减少受试者中的第二肠道微生物群体群体。第一肠道微生物群体包括产生短链脂肪酸（SCFA）的细菌，第二肠道微生物群体包括产生内毒素的细菌。

6. 发明申请

US20150079128A1 CHINESE MEDICINAL FORMULATION FOR TREATING INFLAMMATORY BOWEL DISEASE AND THE PREPARATION THEREOF 有权
标题翻译：用于治疗炎症性皮肤病的中药配方及其制备方法
公开(公告)号：US20150079128A1
公开(公告)日：2015-03-19
申请号：US14029963
申请日：2013-09-18
申请人： Hong Kong Baptist University
发明人： Zhaoxiang Bian , Siu Wai Tsang , Siu Po Ip , Che Yuen Justin Wu , Aiping Lu , Albert Sun Chi Chan
IPC分类号： A61K36/9068 , A61K36/718 , A61K36/076 , A61K36/71 , A61K36/344 , A61K36/284
CPC分类号： A61K36/9068 , A61K36/076 , A61K36/284 , A61K36/344 , A61K36/65 , A61K36/71 , A61K36/718 , A61K2300/00
摘要： This invention relates to a Chinese medicinal formulation for the treatment of inflammatory bowel diseases, and a method of preparation thereof. The formulation comprises herbal components selected from a group consisting of Radix Codonopsis (Dangshen), Rhizoma Atractylodis Macrocephalae (Bai Zhu), Sclerotium Poriae Cocos (Fu Ling), Rhizoma Zingiberis Officinalis (Gan Jiang), Radix Paeoniae Alba (Bai Shao) and Rhizoma Coptidis (Huanglian).
摘要翻译：本发明涉及一种治疗炎性肠病的中药制剂及其制备方法。该制剂包含选自由党参（Dangshen），白术（白芍），茯苓（Fu Ling），an姜（Gan Jiang），白芍（Bai Shao），白芍（Rhizoma）黄连（黄连）。

7. 发明申请

US20140234366A1 COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASE OR MAJOR DEPRESSIVE DISORDER (DEPRESSION) 审中-公开
标题翻译：用于预防或治疗过敏性疾病或主要恶心疾病（DEPRESSION）的组合物
公开(公告)号：US20140234366A1
公开(公告)日：2014-08-21
申请号：US13822864
申请日：2013-02-21
申请人： Yoshiteru Shimoide
发明人： Yoshiteru Shimoide
IPC分类号： A61K36/756 , A61K36/539 , A61K36/744 , A61K36/258 , A61K36/481 , A61K36/284 , A61K36/233 , A61K36/232 , A61K36/71 , A61K36/752 , A61K36/9068 , A61K36/725 , A61K36/484 , A61K36/076 , A61K36/54 , A61K36/718
CPC分类号： A61K36/756 , A61K36/00 , A61K36/076 , A61K36/232 , A61K36/233 , A61K36/258 , A61K36/284 , A61K36/481 , A61K36/484 , A61K36/539 , A61K36/54 , A61K36/71 , A61K36/718 , A61K36/725 , A61K36/744 , A61K36/752 , A61K36/9068 , A61K2300/00
摘要： The invention aims to provide a composition for treating atopic dermatitis, bronchial asthma, allergic rhinitis or major depressive disorder (depression), comprising a mixture of Formula antidoti coptidis (orengedokuto) and Formula repletionis animalis et supletionis medii (hochuekkito) or a mixture of Formula antidoti coptidis (orengedokuto) and Formula glycyrrhizae atractylodis cinnamomi hoelen (ryokeijutsukanto) as active components. Provided is a composition for preventing or treating an allergic disease or major depressive disorder, comprising a mixture of Formula antidoti coptidis (orengedokuto) and Formula repletionis animalis et supletionis medii (hochuekkito) or a mixture of Formula antidoti coptidis (orengedokuto) and Formula glycyrrhizae atractylodis cinnamomi hoelen (ryokeijutsukanto) as active components.
摘要翻译：本发明旨在提供一种用于治疗特应性皮炎，支气管哮喘，过敏性鼻炎或重度抑郁障碍（抑郁症）的组合物，其包含式antidoti coptidis（orengedokuto）和配方补充药物和药物组合物（hochuekkito）或式 antidoti coptidis（orengedokuto）和配方甘草（Atylylodis cinnamomi hoelen）（ryokeijutsukanto）作为活性成分。提供了用于预防或治疗过敏性疾病或重症抑郁障碍的组合物，其包含式antidoti coptidis（orengedokuto）和Formula repletionis animalis et supletionis medii（hochuekkito）或式antidoti coptidis（orengedokuto）和Formula glycyrrhizae atractylodis的混合物的混合物肉桂仁（ryokeijutsukanto）作为活性成分。

8. 发明申请

US20130122127A1 Extract of Coptidis Rhizoma and novel use thereof in treating respiratory disease 有权
标题翻译：黄连提取物及其在治疗呼吸系统疾病中的新用途
公开(公告)号：US20130122127A1
公开(公告)日：2013-05-16
申请号：US13735129
申请日：2013-01-07
申请人： AHN-GOOK PHARMACEUTICAL CO., LTD.
发明人： Jin AUH , Chang-Hwan Kim , Chang-Kyun Han , Sung-Hum Yeon , Young-June Shin , Min-Ki Shin , Soo-Im Chang
IPC分类号： A61K36/718 , A61K36/25
CPC分类号： A61K36/718 , A61K36/25 , A61K2300/00
摘要： A composition for suppressing cough, removing sputum, preventing and/or treating a respiratory disease comprising an extract of Coptidis rhizoma or a combined extract of Coptidis rhizoma with ivy leaf as an active ingredient, and a method of suppressing cough, removing sputum, and/or preventing and/or treating respiratory disease using the composition, are provided.
摘要翻译：抑制咳嗽，清除痰液，预防和/或治疗呼吸系统疾病的组合物，其中包括黄连提取物或黄连提取物与常春藤叶作为有效成分的组合提取物，以及抑制咳嗽，除痰和/ 或使用该组合物预防和/或治疗呼吸系统疾病。

9. 发明申请

US20120171298A1 USE OF PHARMACEUTICAL COMPOSITIONS IN PREPARING PHARMACEUTICALS FOR TREATING DIABETIC ULCER 审中-公开
标题翻译：药物组合物在制备用于治疗糖尿病的药物中的应用
公开(公告)号：US20120171298A1
公开(公告)日：2012-07-05
申请号：US13132066
申请日：2010-01-20
申请人： Rongxiang Xu
发明人： Rongxiang Xu
IPC分类号： A61K36/756 , A61P17/02
CPC分类号： A61K36/75 , A61F13/00012 , A61F13/00063 , A61F13/00072 , A61F13/069 , A61F2013/00161 , A61F2013/0054 , A61F2013/0091 , A61F2013/00927 , A61K9/0014 , A61K9/06 , A61K35/62 , A61K35/644 , A61K36/185 , A61K36/539 , A61K36/66 , A61K36/71 , A61K36/718 , A61K36/756 , A61K47/44 , A61L15/34 , A61L15/40 , A61L15/44 , A61K2300/00
摘要： The use of pharmaceutical compositions in preparing pharmaceuticals for treating diabetic ulcer in limb or on body surface, or in preparing medical dressing. The pharmaceutical compositions consist of (A) 3 to 15% by weight of edible beeswax and (B) 85 to 97% by weight of sesame oil extract of Scutellaria root, Coptis root, Phellodendron bark, earthworm and poppy capsule, based on the total weight of the pharmaceutical compositions. In the sesame oil extract, each of Scutellaria root, Coptis root, Phellodendron bark, earthworm and poppy capsule is in an amount of 2 to 10% by weight of dry raw material based on the total weight of sesame oil. A medical dressing for treating diabetic ulcer and corresponding medicine box enclosing the said dressing are also provided.
摘要翻译：药物组合物在制备用于治疗肢体或身体表面的糖尿病性溃疡或制备医用敷料的药物中的用途。药物组合物由（A）3至15重量％的可食用蜂蜡和（B）85至97重量％的黄芩根，黄连，黄柏树皮，蚯蚓和罂粟胶的芝麻油提取物药物组合物的重量。在芝麻油提取物中，基于芝麻油的总重量，黄芩根，黄连，黄柏，蚯蚓和罂粟胶囊中的每一种都是干燥原料的2至10重量％。还提供了用于治疗糖尿病性溃疡的医用敷料和包围所述敷料的相应药盒。

10. 发明授权

US08003136B2 Standardization of botanical products utilizing biological activity as a marker 失效
标题翻译：以生物活性为标记的植物产品的标准化
公开(公告)号：US08003136B2
公开(公告)日：2011-08-23
申请号：US11882270
申请日：2007-07-31
申请人： Randy Beavers
发明人： Randy Beavers
IPC分类号： A61K36/00 , A61K49/00
CPC分类号： A61K36/29 , A61K36/71 , A61K36/718
摘要： The present invention relates generally to herbal materials and methods for making such materials in medicinally useful and pharmaceutically acceptable forms. Particularly, the present invention relates generally to Hydrastis canadensis (goldenseal) materials and methods for making such materials in medicinally useful and pharmaceutically acceptable forms. More particularly, the present invention relates a process which allows the standardization of the product to specified levels of bioactivity in both hydro-alcoholic tinctures and solid extracts in the processing of goldenseal materials to produce extracts which qualify as pharmaceutical grade compositions which are suitable for use in clinical or veterinary settings to treat and/or ameliorate diseases, disorders or conditions.
摘要翻译：本发明一般涉及草药材料及其制备方法，用于药用和药学上可接受的形式。特别地，本发明一般涉及加拿大芥菜（Goldenseal）材料以及用于制造这些材料的医药上可用和药学上可接受的形式的方法。更具体地说，本发明涉及一种方法，其允许将产品标准化到含水物质加工中的两种水性醇酊剂和固体提取物中的生物活性水平以产生符合作为适合使用的药物级组合物的提取物在临床或兽医环境中治疗和/或改善疾病，病症或病症。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式